Benzinga's Top #PreMarket Losers
January 08, 2015 at 08:22 AM EST
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) shares fell 12.52% to $14.26 in pre-market trading. Infinity Pharmaceuticals' Phase 2 ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.